IRONWOOD PHARMACEUTICALS, INC. (IRWD) Operating cash flow 2016–2025
IRONWOOD PHARMACEUTICALS, INC. (IRWD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$127.0MFY2025 · since FY2016: -$25.9M → $127.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $127.0M | +22.7% |
| FY2024 | $103.5M | -43.5% |
| FY2023 | $183.4M | -33.0% |
| FY2022 | $273.8M | +4.5% |
| FY2021 | $261.9M | +55.1% |
| FY2020 | $168.8M | +1474.2% |
| FY2019 | $10.7M | +115.1% |
| FY2018 | -$70.9M | +29.6% |
| FY2017 | -$100.8M | -288.5% |
| FY2016 | -$25.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice